A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.
Boue F, Pastran Z, Spielmann M, Le Chevalier T, Subirana R, Sevin D, Paoletti C, Brandely M, Avril MF, Sancho-Garnier H, et al.
Boue F, et al. Among authors: spielmann m.
Cancer Immunol Immunother. 1990;32(1):67-70. doi: 10.1007/BF01741727.
Cancer Immunol Immunother. 1990.
PMID: 2126985
Free PMC article.
Clinical Trial.